While the world obsesses over AI-driven diagnostics and flashy digital health apps, Sentec has been building a $108M empire on the unglamorous, life-saving backbone of noninvasive monitoring. They're not chasing buzzwords; they're mastering the physics of gas sensing and transcutaneous measurement to make invasive care a last resort, not a default.

"Sentec isn't selling software; they're selling certainty. Their tech turns the skin into a diagnostic window, eliminating the need for invasive lines."

The company's traffic split—45% organic, 40% direct—signals strong brand recognition in clinical circles. You don't get 40% direct traffic unless physicians, respiratory therapists, and hospital procurement teams are bookmarking your site. Yet, their global rank of #1.6M suggests they're not playing the volume game; they're playing the precision game. Their audience isn't the masses; it's the 431 employees' worth of clinical experts who matter.

• TCM (Transcutaneous Monitoring) enables continuous, noninvasive blood gas analysis—critical for neonatal and ICU care.
• EIT (Electrical Impedance Tomography) provides real-time lung imaging without radiation, revolutionizing respiratory therapy.
• They serve a dual market: clinical healthcare and industrial sensor applications, a rare and resilient business model.